![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2924874/0/en/ANI-Pharmaceuticals-Reports-Second-Quarter-2024-Financial-Results-and-Raises-2024-Guidance.html
https://www.globenewswire.com/news-release/2024/07/31/2921740/0/en/ANI-Pharmaceuticals-to-Discuss-Second-Quarter-2024-Financial-Results-on-August-6-2024-at-8-30-a-m-ET.html
https://www.globenewswire.com/news-release/2024/07/15/2912933/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-L-Glutamine-Oral-Powder.html
https://www.globenewswire.com/news-release/2024/07/02/2907285/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-Naproxen-Delayed-Release-Tablets-USP.html
https://www.globenewswire.com/news-release/2024/06/25/2903655/0/en/ANI-Pharmaceuticals-CEO-Nikhil-Lalwani-Named-EY-Entrepreneur-Of-The-Year-2024-New-Jersey-Award-Winner.html
https://www.contractpharma.com/contents/view_breaking-news/2024-06-24/ani-pharmaceuticals-to-acquire-alimera-sciences/9769
https://www.globenewswire.com//news-release/2024/02/07/2825036/0/en/ANI-Pharmaceuticals-to-Discuss-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-29-2024-at-8-30-a-m-ET.html
https://www.globenewswire.com//news-release/2024/01/23/2813922/0/en/ANI-Pharmaceuticals-Announces-the-Launch-of-Pentoxifylline-Extended-Release-Tablets-USP.html
https://www.globenewswire.com//news-release/2023/11/22/2784858/0/en/ANI-Pharmaceuticals-to-Present-at-the-Piper-Sandler-35th-Annual-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/10/30/2769014/0/en/ANI-Pharmaceuticals-to-Participate-at-Two-Upcoming-Healthcare-Conferences.html